好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2013 Annual Meeting | Leukodystrophies

Sunday 03/17/13
02:00 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Half-Day Course
Adeline Vanderver, MD, FAAN
Participants should become familiar with the differential diagnosis and critiical diagnostic and management steps in different categories of inherited disorders of the white matter.
No CME available
Patient Care & Procedural Skills, Practice-based Learning and Improvement
Subspecialty in Focus
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Audience Participation
Event Timeline
02:00 PM - 02:15 PM New Definition and Overview of MRI Pattern Recognition- An Introduction
Adeline Vanderver, MD, FAAN
02:15 PM - 02:20 PM Questions and Answers
02:20 PM - 03:00 PM Diagnostic Algorithm and the Demyelinating Leukodystrophies
Raphael Schiffmann, MD, FAAN
03:00 PM - 03:05 PM Questions and Answers
03:05 PM - 03:45 PM Diagnostic Algorithm and the Hypomyelinating Leukodystrophies
Genevieve Bernard, MD
03:45 PM - 04:05 PM Break
04:05 PM - 04:40 PM Adult Onset Leukodystrophies
Adeline Vanderver, MD, FAAN
04:40 PM - 04:45 PM Questions and Answers
04:45 PM - 05:30 PM Treatable Entities You Don’t Want to Miss (with a Focus on XALD)
Keith Van Haren, MD
05:30 PM - 05:35 PM Questions and Answers
05:35 PM - 06:00 PM Case Presentations
Faculty Disclosures
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Keith Van Haren, MD Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Genevieve Bernard, MD The institution of Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Passage Bio. Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. The institution of Dr. Bernard has received research support from Takeda. The institution of Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Montreal Children's Foundation. The institution of Dr. Bernard has received research support from Yaya Foundation for 4H Leukodystrophy. The institution of Dr. Bernard has received research support from Fondation Les Amis d'Elliot. The institution of Dr. Bernard has received research support from Pelizaeus-Merzbacher Disease Foundation. Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Ionis. The institution of Dr. Bernard has received research support from Passage Bio.
Raphael Schiffmann, MD, FAAN No disclosure on file